Tag: AstraZeneca vaccine
RIO DE JANEIRO, BRAZIL - The global debate of Covid mRNA vaccine mandates and passports has ignited social media, policymakers, and policies that impact just nearly every aspect of public life.
According to a new Israeli study, the natural immune...
RIO DE JANEIRO, BRAZIL - The National Health Regulator (ANVISA) proposed to suspend the application of vaccines against Covid-19 from both AstraZeneca and Janssen in pregnant women. The recommendation applies to immunizers that use adenoviral vectors. Thus, Brazilian pregnant...
RIO DE JANEIRO, BRAZIL - Pfizer-BioNTech's vaccine is highly effective against the Delta coronavirus variant, an Israeli Pfizer official said Thursday. First identified in India, the Delta is becoming the dominant coronavirus variant worldwide, according to the World Health...
RIO DE JANEIRO, BRAZIL - Argentina has received so far, from several international suppliers, more than 15 million vaccine doses against Covid-19, of which 8,878,491 first doses have already been applied, 19.38 % of the population, and 2,452,575 second...
RIO DE JANEIRO, BRAZIL - Argentina has already recorded more than 68,000 deaths due to Covid-19 at a time when, despite the progress made in vaccination, there is still no light at the end of the tunnel due to...
RIO DE JANEIRO, BRAZIL - "We do not know for how long we will have to face this disease, but national production will ensure that we can vaccinate Brazilians every year, regardless of the variants that may arise," said...
RIO DE JANEIRO, BRAZIL - In a press conference in Manaus, the capital of the state of Amazonas, Health Minister Pazuello reported that a plane was flying to India to collect two million doses of the vaccine developed by...
RIO DE JANEIRO, BRAZIL - Piauí Governor and vaccine coordinator at the Governors Forum Wellington Dias said that the Oswaldo Cruz Foundation (Fiocruz) will apply for the emergency use of the Oxford vaccine against Covid-19 to the National Health...
RIO DE JANEIRO, BRAZIL - The UK-based pharmaceutical company AstraZeneca has been conducting late-stage trials of its vaccine, developed with Oxford University, in Chile as well as in Brazil, the UK, the United States and South Africa.
Chile has signed...